GENE ONLINE|News &
Opinion
Blog

Chronic Myeloid Leukemia
Novartis’ Treatment for Rare Cancer Wins European Commission’s Approval
2022-08-29
R&D
Novartis’ Chronic Myeloid Leukemia Drug Demonstrates Superior Results to Pfizer’s
2020-12-10
Novartis’ Asciminib Shines in Chronic Myeloid Leukemia Trial
2020-08-28
CRISPR Helps Unearth Novel drug Target for Leukemia
2020-04-23
LATEST
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
2023-03-24
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
Scroll to Top